Phase 2 IMPACT trial results show that adding certolizumab pegol to standard heparin and aspirin significantly lowers adverse pregnancy outcomes in high-risk antiphospholipid syndrome.

Smartwatches significantly overestimate how many calories people burn during exercise, according to a study published online ...

Areas under curve were 0.79, 0.78, and 0.86 for hypertension, ischemic heart disease, and cerebrovascular accident, respectively.

Stage 1 to 3 CKM syndrome linked to significantly higher mean-mean, mean-maximum carotid intima-medial thickness.

Phase 3 HAELO data showed an 87% reduction in monthly attack rates with Ionvoguran ziclumeran, with a PDUFA target date of March 10, 2027.